June 26, 2023
GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants
June 20, 2023
GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients
May 24, 2023
GeneDx to Participate in Upcoming Investor Conferences in June
May 23, 2023
GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations
May 22, 2023
GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 9, 2023
GeneDx Reports First Quarter 2023 Financial Results and Business Highlights
May 4, 2023
GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option
May 3, 2023
GeneDx Announces Clarification Regarding CUSIP Number for Public Warrant Holders
April 28, 2023
GeneDx Announces Reverse Stock Split
April 18, 2023
GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
Displaying 11 - 20 of 33